Open AccessSHPA Standards of Practice for Pharmacy Investigational Drugs Services The Society of Hospital Pharmacists of Australia Committee of Specialty Practice in Investigational Drugs
Author(s) -
Hynes Kay,
Naismith Neil,
Matthews Helen,
Bingham Judy,
Choo Shin,
Kopp Helen,
Fong Lorraine,
Ewart Sue
Publication year - 1999
Publication title -
the australian journal of hospital pharmacy
Language(s) - English
Resource type - Journals
ISSN - 0310-6810
DOI - 10.1002/jppr1999294227
Subject(s) - investigational drugs , pharmacy , medicine , specialty , nuclear pharmacy , clinical trial , health care , family medicine , clinical pharmacy , pharmaconomist , political science , law
These standards have been developed for pharmacists involved with investigational drugs in their institutions and replace the previously published ‘SHPA Policy Guidelines for Investigational Drugs’. 1 This document deals with investigational drugs used in clinical trials and under the Special Access Scheme (SAS). 2 Hospitals and other healthcare agencies are the major centres for clinical studies with investigational drugs and pharmacists in these institutions should be involved with policies and procedures for the safe and ethical use of these drugs.